Insulin Glargine
Helps maintain steady blood sugar levels throughout the day, supporting metabolic health for people with diabetes.
This peptide is an FDA-approved drug product that can be legally prescribed by licensed clinicians.
The basics
- Generic Name
- insulin glargine
- Brand Names
- Lantus, Basaglar, Toujeo
- Regulatory Status
- Prescribed by Doctors
- Therapeutic Areas
- Metabolic & Weight Management, Endocrine
- Prescribing Specialties
- Primary care, Endocrinology
What it does
Insulin Glargine is an FDA-approved medication that your doctor can prescribe. Long-acting basal insulin analog that provides a steady level of insulin over approximately 24 hours, helping to regulate blood glucose levels.
How it's taken
Daily subcutaneous injection
How people access it
Widely prescribed for diabetes. Available at any retail pharmacy. Well-established insurance coverage.
What doctors prescribe it for
- Improve glycemic control in adults and pediatric patients with type 1 diabetes mellitus
- Improve glycemic control in adults with type 2 diabetes mellitus
Clinicians may prescribe FDA-approved drugs for off-label uses based on their clinical judgment. Off-label indications have not undergone the same FDA review process as the labeled uses listed above.
How to know it's legit
You can independently verify the FDA-approval status of Insulin Glargine through these free, publicly available databases:
- DailyMed (dailymed.nlm.nih.gov) — Search for Lantus to find the current FDA-approved labeling, including indications, dosing, warnings, and contraindications.
- Drugs@FDA (accessdata.fda.gov/scripts/cder/daf/) — Search to find the original approval letter, review documents, and approval history.
- FDA Orange Book (orangebook.fda.gov) — Search for therapeutic equivalence evaluations and patent/exclusivity information.
Common Questions
Yes. Insulin Glargine (Lantus, Basaglar, Toujeo) is an FDA-approved drug product. It has undergone rigorous review of safety, efficacy, and manufacturing quality by the FDA. It can be legally prescribed by licensed clinicians for its approved indications.
Insulin Glargine is FDA-approved for: Improve glycemic control in adults and pediatric patients with type 1 diabetes mellitus; Improve glycemic control in adults with type 2 diabetes mellitus. Off-label use may be considered by clinicians on a case-by-case basis, but only the labeled indications have been reviewed and approved by the FDA.
You can verify the approval status of Insulin Glargine through several official FDA resources: DailyMed (dailymed.nlm.nih.gov) for current labeling, Drugs@FDA (accessdata.fda.gov/scripts/cder/daf/) for approval history, and the FDA Orange Book for therapeutic equivalence information. These are free, publicly available databases.
Want to learn more?
Explore how Insulin Glargine compares to other options, or dive deeper into how FDA approval works.
Explore All Peptides